Table 1.
MYC group n = 22 | CTRL group n = 28 | p-Value | |
---|---|---|---|
Gender, male | 13 (59) | 9 (32) | 0.086 |
Age (years) | 12.1 (2.7–16.4) | 5.0 (3.0–6.8) | 0.042 |
BSA (kg/m2) | 1.6 (0.6–1.8) | 0.8 (0.6–1.2) | 0.063 |
Echocardiography | |||
Z-score LVIDd (mm) | 1.9 (0.1–5.3) | −0.8 (−1.6–0.4) | <0.001 |
LVEF (%) | 51.0 (28.0–60.0) | 63.5 (57.8–72.3) | <0.001 |
Antibody levels | |||
Anti-β1-AR Ab (U/ml) | 7.7 (3.8–24.3) | 5.0 (3.7–8.2) | 0.125 |
Anti-β2-AR Ab (U/ml) | 6.0 (2.4–19.9) | 3.6 (2.6–4.7) | 0.077 |
Anti-β3-AR Ab (U/ml) | 6.4 (2.9–18.8) | 3.5 (3.0–6.8) | 0.035 |
Values are given as n (%) or median (interquartile range).
Anti-β-AR Ab, anti-beta-adrenergic antibodies; BSA, body surface area; LVEF, left ventricular ejection fraction; LVIDd, left ventricular internal diastolic diameter. Bold values represents significant values.